[go: up one dir, main page]

DK1370279T3 - Anvendelse af det lange pentraxin PTX3 til fremstilling af et lægemiddel til forebyggelse og helbredelse af autoimmuni patologier - Google Patents

Anvendelse af det lange pentraxin PTX3 til fremstilling af et lægemiddel til forebyggelse og helbredelse af autoimmuni patologier

Info

Publication number
DK1370279T3
DK1370279T3 DK01983771T DK01983771T DK1370279T3 DK 1370279 T3 DK1370279 T3 DK 1370279T3 DK 01983771 T DK01983771 T DK 01983771T DK 01983771 T DK01983771 T DK 01983771T DK 1370279 T3 DK1370279 T3 DK 1370279T3
Authority
DK
Denmark
Prior art keywords
cure
prevention
drug
manufacture
autoimmune pathologies
Prior art date
Application number
DK01983771T
Other languages
English (en)
Inventor
Alberto Mantovani
Barbara Bottazi
Giuseppe Peri
Angelo Manfredi
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1370279T3 publication Critical patent/DK1370279T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01983771T 2000-11-03 2001-10-18 Anvendelse af det lange pentraxin PTX3 til fremstilling af et lægemiddel til forebyggelse og helbredelse af autoimmuni patologier DK1370279T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000571A IT1317927B1 (it) 2000-11-03 2000-11-03 Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.

Publications (1)

Publication Number Publication Date
DK1370279T3 true DK1370279T3 (da) 2006-01-23

Family

ID=11454977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01983771T DK1370279T3 (da) 2000-11-03 2001-10-18 Anvendelse af det lange pentraxin PTX3 til fremstilling af et lægemiddel til forebyggelse og helbredelse af autoimmuni patologier

Country Status (19)

Country Link
US (1) US20040029803A1 (da)
EP (1) EP1370279B1 (da)
JP (1) JP4105542B2 (da)
KR (1) KR100812805B1 (da)
CN (1) CN1326563C (da)
AT (1) ATE303819T1 (da)
AU (2) AU1518902A (da)
BR (1) BR0115050A (da)
CA (1) CA2427533A1 (da)
CZ (1) CZ297242B6 (da)
DE (1) DE60113304T2 (da)
DK (1) DK1370279T3 (da)
ES (1) ES2248401T3 (da)
HU (1) HUP0401593A2 (da)
IT (1) IT1317927B1 (da)
MX (1) MXPA03003805A (da)
PL (1) PL365291A1 (da)
SK (1) SK5332003A3 (da)
WO (1) WO2002036151A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
ITRM20020109A1 (it) * 2002-02-28 2003-08-28 Sigma Tau Ind Farmaceuti Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.
EP1599226B1 (en) * 2003-02-21 2012-09-19 Medvet Science Pty. Ltd. A method of diagnosis and treatment
ITRM20030595A1 (it) * 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso della ptx3 o di un suo derivato funzionale da sola o in associazione con tsg6 per il trattamento di patologie degenarative dell'osso o della cartilagine e per il trattamento della infertilita' femminile.
ITRM20030596A1 (it) * 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
US8337828B2 (en) 2006-05-02 2012-12-25 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection
KR101305515B1 (ko) 2011-06-10 2013-09-06 경북대학교 산학협력단 펜트락신 3 단백질의 파킨슨 질환 진단 용도
US20150299277A1 (en) * 2012-06-22 2015-10-22 The University Of Tokyo Agent for treating or preventing systemic inflammatory response syndrome
CN105903001A (zh) * 2016-05-09 2016-08-31 中国科学院海洋研究所 一种鱼类穿透素的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
US6013217A (en) * 1997-12-22 2000-01-11 Dow Corning Corporation Method for extruding thermoplastic resins

Also Published As

Publication number Publication date
SK5332003A3 (en) 2003-12-02
CN1326563C (zh) 2007-07-18
WO2002036151A2 (en) 2002-05-10
HK1071291A1 (en) 2005-07-15
ATE303819T1 (de) 2005-09-15
CN1561226A (zh) 2005-01-05
CA2427533A1 (en) 2002-05-10
AU1518902A (en) 2002-05-15
JP2004512372A (ja) 2004-04-22
WO2002036151A3 (en) 2003-10-16
US20040029803A1 (en) 2004-02-12
HUP0401593A2 (hu) 2004-12-28
PL365291A1 (en) 2004-12-27
CZ297242B6 (cs) 2006-10-11
EP1370279B1 (en) 2005-09-07
KR20030060918A (ko) 2003-07-16
DE60113304T2 (de) 2006-06-08
CZ20031043A3 (cs) 2003-09-17
ITRM20000571A1 (it) 2002-05-03
JP4105542B2 (ja) 2008-06-25
AU2002215189B2 (en) 2006-08-03
EP1370279A2 (en) 2003-12-17
ITRM20000571A0 (it) 2000-11-03
KR100812805B1 (ko) 2008-03-12
IT1317927B1 (it) 2003-07-15
DE60113304D1 (de) 2005-10-13
ES2248401T3 (es) 2006-03-16
MXPA03003805A (es) 2004-04-20
BR0115050A (pt) 2003-09-30

Similar Documents

Publication Publication Date Title
PT1221918E (pt) Administracao de drogas sub-tenon
NO20024099D0 (no) Lavdose entecavir-formulering og anvendelse
AR027998A1 (es) Derivados de etilendiamina y los medicamentos y composiciones farmaceuticas que los contienen
DK1263490T3 (da) Nålefri injektionsindretning i minitureudförelse
DE69822168D1 (de) Dentale anästhesie- und verabreichungsinjektionseinheit
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
DK1354888T3 (da) Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
DK1196409T3 (da) Respiratoriske syncytilvirusreplikationsinhibitorer
FR2810553B1 (fr) Dispositif implantable d'administration de reactif et de detention
EE05123B1 (et) Antiprogestiinsete omadustega ravimite manustamise vahendid
DK1370279T3 (da) Anvendelse af det lange pentraxin PTX3 til fremstilling af et lægemiddel til forebyggelse og helbredelse af autoimmuni patologier
IS6508A (is) Lyfjasamsetningar af glycogen fosfórýlasa lötum
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
EE05020B1 (et) Glburiidi ravimkoostis
IS7065A (is) Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð
DK1390042T3 (da) System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse
IS2841B (is) Samstæða hluta og lyfjasamsetningar
NO20030759L (no) 10-aryl-11-HBENZO(b)fluorenderivater og analoger for medisinsk anvendelse
PT1164996E (pt) Sistemas terapeuticos transdermicos com nicotina e adicao de cetonas monoterpenicas
PT1438336E (pt) Formulacoes de fsh com um nivel elevado de sialilacao e sua utilizacao na preparacao de medicamentos
AR030140A1 (es) Composiciones derivadas de la 2-piridinamina y metodos relacionados
EP1311239A4 (en) ORAL PEPTIDE ADMINISTRATION